ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Medicine Man Technologies Inc (CE)

Medicine Man Technologies Inc (CE) (SHWZ)

0.0055
-0.0145
(-72.50%)
Cerrado 26 Febrero 3:00PM
Gráfico avanzado

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.0055
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
620
0.0033 Rango del Día 0.0055
0.000001 Rango de 52 semanas 1.38
Precio Anterior
0.02
Precio de Apertura
0.0033
Última hora de negociación
Volumen promedio (3 m)
14,917
Volumen financiero
US$ 3
Precio Promedio Ponderado
0.004675

SHWZ Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0005-8.333333333330.0060.021.0E-658250.01775307CS
4-0.00565-50.67264573990.011150.041.0E-645660.01673466CS
12-0.0945-94.50.10.131.0E-6149170.03928889CS
26-0.1045-950.110.31.0E-6121590.08517839CS
52-1.2045-99.54545454551.211.381.0E-6434010.47014646CS
156-1.7345-99.6839080461.742.351.0E-6555501.05657707CS
260-2.4445-99.77551020412.453.251.0E-6738221.55227093CS

SHWZ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Medicine Man Technologies (CE)?
El precio actual de las acciones de Medicine Man Technologies (CE) es US$ 0.0055
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Medicine Man Technologies (CE)?
Medicine Man Technologies (CE) ha negociado en un rango de US$ 0.000001 a US$ 1.38 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
100
FGHFFForte Group Holdings Inc (PK)
US$ 0.30
(19,900.00%)
175
PRSTPresto Automation Inc (CE)
US$ 0.0002
(19,900.00%)
250.65k
SBESSouth Beach Spirits Inc (CE)
US$ 0.0002
(19,900.00%)
2.99M
MADIMadison Systems Inc (CE)
US$ 0.025
(12,400.00%)
5k
AMBSAmarantus Bioscience Holdings Inc (CE)
US$ 0.000001
(-99.80%)
2.09M
FBECFBEC Worldwide Inc (CE)
US$ 0.000001
(-99.80%)
256.4k
QBIOQ BioMed Inc (CE)
US$ 0.000001
(-99.67%)
9.6k
VELXQCanadian Overseas Petroleum Ltd (CE)
US$ 0.000001
(-99.67%)
40.8k
IMTLImage Protect Inc (PK)
US$ 0.000001
(-99.50%)
10.93M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
192.02M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(0.00%)
129.45M
BIELBioelectronics Corp (PK)
US$ 0.0002
(-20.00%)
124.1M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0026
(-3.70%)
116.32M
HMBLHUMBL Inc (PK)
US$ 0.0004
(-20.00%)
111.68M

SHWZ Discussion

Ver más
Chichus Chichus 1 día hace
https://nmcannabischamber.org/events
👍️0
Drugdoctor Drugdoctor 4 días hace
Nothing like a good ole Starbuds app for your phone. https://starbudscolorado.com/sb-mobile-app/
👍️0
lazur lazur 5 días hace
I still have like 100 shares and I looked at my fidelity account and saw a .39 price and up 1000% on the portfolio view. But Yahoo is even better, showing it up 109,900% at .0011 - well that would have been a fun play to make with even a $1000 investment!
👍️0
StevenRisk StevenRisk 7 días hace
Bout sums it up! Really would like management to come clean with why this is taking so long .
👍️0
lazur lazur 1 semana hace
Correct. I don't see any bright spots in pot as a whole. Most companies are debt ridden, barely hanging on, getting taxed out the wazoo, no longer any discussions of even advancing fed level changes to assist them. SHWZ is in a hole of their own making, with a price of 2 cents which of course is mythical - who knows what the price will be if they ever get their finances in order, and again, why is it taking so long? I haven't been paying much attention here since I got out on the slide, but not early enough to escape a haircut. I just don't see any reason beyond pure gambling to invest in almost any stock in the sector, certainly not one shooting its own foot as SHWZ has been doing on top of the larger sector challenges. Good luck to any of those sticking it out through this soap opera.
👍️ 1
StevenRisk StevenRisk 2 semanas hace
Certainly not a positive article for SHWZ. I think while it is bleak not sure totally as negative as presented. Depending on where your at on the food chain many debt holders would be screwed imo. The assets SHWZ hold are not worth even close to what they paid at currently without changes in the law. I think debt holders and management need to move forward to solutions and not so much to dilution nor forced liquidation. While stakeholders would definitely be worthless most bondholders would lose as assets would not even come close to covering debt. Apparently bk is not an option. Of course IMO.
👍️0
StevenRisk StevenRisk 2 semanas hace
Certainly not a positive article for SHWZ. I think while it is bleak not sure totally as negative as presented. Depending on where your at on the food chain many debt holders would be screwed imo. The assets SHWZ hold are not worth even close to what they paid at currently without changes in the law. I think debt holders and management need to move forward to solutions and not so much to dilution nor forced liquidation. While stakeholders would definitely be worthless most bondholders would lose as assets would not even come close to covering debt. Apparently bk is not an option. Of course IMO.
👍️ 1
Chichus Chichus 2 semanas hace
https://finance.yahoo.com/news/cannabis-industry-faces-debt-reckoning-153255385.html
👍️0
olivernoyes olivernoyes 3 semanas hace
Same here, I try not to look at them, but it's hard. This whole industry shot itself in the foot by overhyping things and WAY overbuilding in anticipation of this huge TAM, not recognizing that we still live in a world where a bunch of crusty old white guys, who are still hung up on reefer madness, hold the keys to unlocking the industry. Meanwhile you have good ole boy Mitch McConnell (for years) not lifting a finger to fix the farm bill loophole. I am sure back in Kentucky they are growing hemp to beat the band, bottling it up, and selling it at every corner gas station.

I see the same thing happening again right now with this whole AI hype cycle. These companies are spending BILLIONS of dollars in a race to build out these enormous data centers all over the country, and then some Chinese tech bros solve the problem in their basement with a cheaper faster version over the weekend. Boom!! The entire industry now has to re-think itself.
👍️ 1
damAcon1 damAcon1 3 semanas hace
I try not to look at it...and really the entire industry, anymore. Annoyed that the constant bullishness keeps happening regardless of reality over the last 8 years since I started investing in it...some "analysts" huh?! At this point wake me up when something at the federal level happens, and until then, this industry will remain a house-of-cards, insider enrichment scheme.
👍️0
Drugdoctor Drugdoctor 3 semanas hace
That's one way to look at it... When we saw .000001 though, it was very discouraging...
👍️0
StevenRisk StevenRisk 3 semanas hace
Thx for responce. I e-mailed them and never heard a word. Atleast a glimmer of hope. Again thx.
👍️ 1
damAcon1 damAcon1 3 semanas hace
Honestly, as long as the company is planning to trade the stock again...I would not be upset if they continue to stay in this purgatory period until there is positive (govt) news to move the stock back to an honorable share price. Cannabis stocks are still moving the wrong direction...remaining on the sidelines at least controls the bleeding.
👍️0
olivernoyes olivernoyes 3 semanas hace
I agree, and I am still cautiously optimistic...it's just taking an awfully long time to re-do these financial statements. I've worked with outside auditors before. It shouldn't take this long. Makes me wonder WHY it's taking so long.
👍️0
Drugdoctor Drugdoctor 3 semanas hace
Well, actually they said they are still planning to file and get back compliant. That's a good answer if you ask me. Thank you for the post.
👍️ 1
olivernoyes olivernoyes 3 semanas hace
I wrote to them this morning. Here is the non-answer I got back...

Thank you for your support as a shareholder.

As you may have seen, we released a press release in December providing an update on our delayed filings. Here is a link to the release - https://www.globenewswire.com/news-release/2024/12/04/2991917/0/en/Schwazze-Provides-Update-on-Delayed-Filings.html.

While we have not announced a specific timeline for the restatement process, please know that we are fully dedicated to completing it as swiftly as possible to regain compliance with SEC requirements. We have no further update at this time.

Best,

Aaron D’Souza

O: (720) 330-2829

501 South Cherry St, Suite 1100

Denver, CO 80246

aaron@elevate-ir.com | www.elevate-ir.com | LinkedIn
👍️ 1
olivernoyes olivernoyes 3 semanas hace
Hmmmm...I guess I'll be doing some tax loss harvesting this year. Ugh.
👍️0
StevenRisk StevenRisk 3 semanas hace
I think we are beyond hope. Where is Dye hiding? He continued flaunting the great financilals and the best management team ever. My guess is they either take in private or filing bankruptcy. With statements made can management legally hide from a shareholder lawsuit?
👍️ 1
olivernoyes olivernoyes 3 semanas hace
Hopefully has something to do with them getting their audits completed and being re-listed on an actual exchange where we can trade again? Fingers crossed. The alternate explanation is they just went bankrupt or took it private???
👍️0
Drugdoctor Drugdoctor 3 semanas hace
WTF??? .000001???
👍️0
StevenRisk StevenRisk 3 semanas hace
The end us near.
👍️0
StevenRisk StevenRisk 1 mes hace
Even accredited investors want no part of this. Some guy on Yahoo is talking about litigation.
👍️0
olivernoyes olivernoyes 2 meses hace
Maybe Kim will acquire them? Trulieve will start swallowing up the smaller fish. GTI maybe?
👍️0
StevenRisk StevenRisk 2 meses hace
I still have a small amount here hoping for the best. Currently most of my money us in interest paying dividends such as ko kmb hsy , pm, mis etc. I believe bankruptcy is not out of the question for shwz. Who knows it could have been part of a plan all along. Hope not!
👍️0
lazur lazur 2 meses hace
You and Stevenrisk may be the last two people on the planet interested in seeing the audit and financials completed. And with any US regulation changes tabled more than likely for the foreseeable future (invading the EU seems more important at the moment), I don't see what is going to recharge the sector this year. More than likely, most of these smaller companies will continue to shrivel and die on the vine, rotting under their debt and taxes. SHWZ doesn't seem remotely interested in its investors any longer. I return out of curiosity to see what comes of this, but it would be difficult to convince me to lay a dime on the company again after the past year, except to play any momentary potential bounce and then get out again.
👍️0
Drugdoctor Drugdoctor 2 meses hace
Wow, still crickets 8 days into the New Year. Surely the accounting firm should have some idea of a timeline for publication by now! Shareholders deserve better from an "open" "shareholder friendly" management.
👍️0
StevenRisk StevenRisk 2 meses hace
Tax selling ends today! Now get the financials out!
👍️0
Drugdoctor Drugdoctor 2 meses hace
Yea, when they first went expert I posted that I expected it would take until the end of the year at the earliest to get the financials reaudited and to resume trading. Now I think that by end of Q1, 2025 is a likely target. So the company is open, is still able to do business, but they are not able to readily access the capital markets and continue growth. I think the upside to all of this is now they can concentrate on their stores that are open, make them more profitable, and continue to pay down the debt. If they begin trading, and Elon Musk pushes for logical Federal weed laws that don't conflict with State weed laws, I believe this stock will do well once trading resumes. Merry Christmas and Happy New Year all, and remember, there is no X in Christmas!
👍️0
StevenRisk StevenRisk 2 meses hace
A lump of coal it is for shareholders this X-Mas. GLTA...MERRY Christmas to all.
👍️0
Drugdoctor Drugdoctor 2 meses hace
Schwazze the Pheonix!
👍️0
railrider railrider 2 meses hace
Is there any hope at all for this dog to rise again?
👍️0
StevenRisk StevenRisk 2 meses hace
I like the restricted stock. It would be nice to see the metrics he has to get in order to receive additional cash compensation. Would that be filed in an 8k?
👍️0
Drugdoctor Drugdoctor 2 meses hace
Yea, I predicted it would be late in the year before they got some filed... and it is late in the year. They really need to get caught up.
👍️0
StevenRisk StevenRisk 2 meses hace
That should be a positive imo. Now let's start getting financials out.
👍️0
Drugdoctor Drugdoctor 2 meses hace
Appointment of Forrest Hoffmaster as Chief Executive Officer



Effective December 9, 2024, the board of directors (the “Board”) for the Company appointed Forrest Hoffmaster as the Company’s Chief Executive Officer (“CEO”). Mr. Hoffmaster was first employed by the Company as the Chief Financial Officer (“CFO”) starting on January 16, 2023, and he previously served as the Company’s Interim Chief Executive Officer and Chief Financial Officer from February 21, 2024 to December 9, 2024. At this time, Mr. Hoffmaster will continue to serve as the CFO of the Company until a successor is duly appointed by the Board, which has hired an executive search firm to find a qualified candidate.



Mr. Hoffmaster brings over 30 years of executive experience in finance and operations for both public and private companies. Prior to joining the Company, Mr. Hoffmaster served as CEO of New Seasons Market, a specialty gourmet food retailer, where he navigated the company through one of the most disruptive periods in the retail grocery industry. Under his leadership, Mr. Hoffmaster implemented a focused growth and cost optimization program, enabling the company to grow EBITDA by over 30% in two years. Prior to New Seasons Market, Mr. Hoffmaster held leadership positions with other leading grocers including Whole Foods Market and H-E-B.









In connection with his appointment as CEO, Mr. Hoffmaster and the Company entered into a Second Amended and Restated Employment Agreement (the “Hoffmaster Employment Agreement”), dated as of December 9, 2024, that governs the terms of Mr. Hoffmaster’s appointment as CEO. Under the terms of the Hoffmaster Employment Agreement, the Board has agreed to (a) increase Mr. Hoffmaster’s base annual salary from $400,000 to $480,000, (b) provide a cash bonus of $14,000 that is payable before the end of 2024 and the opportunity to receive an annual cash bonus of 100% up to 150% of his base salary, based on meeting performance metrics and other terms determined at the Board discretion; (c) grant him 2,500,000 restricted stock units (“RSUs”), vesting in four equal installments on the first, second, third and fourth anniversary of Mr. Hoffmaster’s appointment, with accelerated vesting upon the earlier of (i) a change in control or (ii) the termination of the agreement (x) by Mr. Hoffmaster due to a material breach of the agreement by the Company, (y) by the Company without cause, or (z) as a result of Mr. Hoffmaster’s death or disability; and (d) if the combined value of the options, RSUs, warrants, securities, derivative securities, Performance Stock Units (“PSUs”) or other equity (collectively, “Equity”) in the Company that Mr. Hoffmaster holds does not exceed $2,500,000 (pretax), then at the time of a change of control of the Company, the Company shall compensate Mr. Hoffmaster the difference between the value of Mr. Hoffmaster’s Equity as of the appointment date and the $2,500,000. The Hoffmaster Employment Agreement supersedes and terminates all previous employment agreements entered into by and between Mr. Hoffmaster and the Company.



The complete terms and conditions of Mr. Hoffmaster’s appointment and employment with the Company are set forth in the Hoffmaster Employment Agreement, dated December 9, 2024, between Mr. Hoffmaster and the Company, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
👍️0
Drugdoctor Drugdoctor 3 meses hace
Well that's encouraging. Much better than the garbage Benzinga has been making up and posting.
👍️0
Chichus Chichus 3 meses hace
https://dashboard.channelchek.com/wp-content/uploads/pdf/SHWZ_20241209_27162.pdf
👍️0
Drugdoctor Drugdoctor 3 meses hace
You can't buy it. Their accountant got banned by the SEC and they are now only trading on the expert market because they are having to refile 2 years worth of financials and it's taking longer than the OTC market will allow.
👍 1
Cabocat1 Cabocat1 3 meses hace
I've been gone over a year and I guess things have really changed here. Is anybody buying this down here?
👍️0
Drugdoctor Drugdoctor 3 meses hace
Link to today's SEC 8k filing .. https://ih.advfn.com/stock-market/USOTC/medicine-man-technologies-ce-SHWZ/stock-news/95038478/form-8-k-current-report
👍️0
Drugdoctor Drugdoctor 3 meses hace
NEWS-DENVER , Dec. 04, 2024 (GLOBE-NEWSWIRE) SHWZ is providing an update on its previously announced delayed filings.
On November 29, 2024 , the Audit Committee of the Company determined, following discussions with Baker Tilly and the Company’s management, that the Company’s previously issued audited consolidated financial statements for the two fiscal years ended December 31, 2023 , audited by BF Borgers, and the Company’s unaudited condensed consolidated financial statements and the notes thereto as of and for the fiscal periods ended March 31, 2023 , June 30, 2023 , and September 30, 2023 included in the Company’s Quarterly Reports on Form 10-Q for the fiscal periods ended March 31, 2023 , June 30, 2023 , and September 30, 2023 that were filed with the SEC (collectively the “Subject Periods”) will be restated due to the identification of certain accounting adjustments needed primarily relating to technical accounting areas.
The Company has concluded that the impact of these corrections is material and as a result, the Subject Periods should no longer be relied upon. Similarly, any previously issued or filed reports, press releases, earnings releases, investor presentations or other communications of the Company describing the Company’s financial results or other financial information should no longer be relied upon to the extent that they are related to the Subject Periods.
Schwazze does not currently believe that the foregoing corrections will have any negative material impact on the Company’s revenue, adjusted EBITDA, cash from operations or cash position.
Additional details on the impact of these adjustments can be found in the Company’s related Form 8-K filed earlier today.
👍️0
Drugdoctor Drugdoctor 3 meses hace
Medicine Man Technologies, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Quarterly Report on Form 10-Q”) on or prior to November 14, 2024, without unreasonable effort and expense for the reasons stated below.



The ongoing impact of the May 3, 2024, U.S. Securities Exchange Commission (“SEC”) order (the “SEC Order”) against B.F. Borgers CPA PC and Benjamin F. Borgers (individually and together, “Borgers”), pursuant to which the SEC suspended Borgers from appearing or practicing before the SEC as an accountant, has been significantly challenging for the Company. Borgers was the Company’s independent auditor for the fiscal year ending December 31, 2023, during which time Borgers reviewed Company financial statements and performed reviews of interim financial statements.



In April 2024, the Company engaged Baker Tilly to provide a re-audit of the Company’s year-end December 31, 2023 financial statements as filed on the Annual Report on Form 10-K and the interim quarterly statement for the three-months ending March 31, 2023, as filed in the Quarterly Report on Form 10-Q, the interim quarterly statement for the six-months ending June 30, 2023, as filed in the Quarterly Report on Form 10-Q, and the interim quarterly statement for the nine-months ending September 30, 2023, as filed in the Quarterly Report on Form 10-Q. The extent of the SEC Order’s impact has been significant on the Company’s financial statements as of and for the fiscal quarters ending March 31, 2024, June 30, 2024, and September 30, 2024, to be included in the Quarterly Report filed on Form 10-Q, and its financial statements as of and for the year ended December 31, 2023 included in its Annual Report on Form 10-K.



The impact of the SEC Order has required the Company to undergo a re-audit of the Company’s; (i) year-end December 31, 2023, financial statements as filed on the Annual Report on Form 10-K; (ii) the interim quarterly statement for the three-months ending March 31, 2023, as filed in the Quarterly Report on Form 10-Q, in order to file our Quarterly Report on Form 10-Q for the three-months ending March 31, 2024; (iii) the interim quarterly statement for the six-months ending June 30, 2023, as filed in the Quarterly Report on Form 10-Q, in order to file our Quarterly Report on Form 10-Q for the six-months ended June 30, 2024; and (iv) the interim quarterly statement for the nine-months ending September 30, 2023, as filed in the Quarterly Report on Form 10-Q, in order to file our Quarterly Report on Form 10-Q for the nine-months ending September 30, 2024. As stated in the SEC Order, Form 10-Q filings on or after the date of the SEC Order may not present financial information that has been reviewed by Borgers. Each quarterly period presented in Form 10-Q filings on or after the date of the SEC Order must be reviewed by a qualified, independent, PCAOB-registered public accountant that is permitted to appear or practice before the Commission.



Based on the scope of the re-audit of the Company’s financials noted above, Baker Tilly has had insufficient time to re-audit the Company’s financials by the required filing date of the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. The Company will use its best efforts to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 within the extension period provided under rule 12b-25, however there can be no assurances as the timing of the filing is contingent on Baker Tilly’s re-audit of the Company’s financials noted above.
👍️0
Drugdoctor Drugdoctor 3 meses hace
I would expect a couple of financials to be filed before year end. The company is awfully quiet right now.
👍️0
Drugdoctor Drugdoctor 3 meses hace
Now hiring - 41 positions open. https://secure2.entertimeonline.com/ta/Schwazze.careers?CareersSearch=&lang=EN
👍️0
Drugdoctor Drugdoctor 3 meses hace
$SHWZ has traded 50,000 shares on the expert market today, all below .13. I guess folks are tax loss selling, as we still haven't seen the new audited financials they are expected to file. On one of the videos I watched, Justin Dye said they were going to start up promotions late in this year. It's beginning to look like that might be pushed back to 2025 now...
👍️0
Chichus Chichus 3 meses hace
https://www.benzinga.com/government/regulations/24/11/42127449/colorados-marijuana-sales-tax-revenue-slump-amid-hemp-competition
👍️0
Drugdoctor Drugdoctor 3 meses hace
Thanks for that update... Hope to see some updated filings hitting any day now.
👍️0
In Plain Sight In Plain Sight 3 meses hace
...---... (save our stock)

New R. Greenleaf dispensary coming to the four corners area: 4000 W Main St, Farmington, NM, 87401, United States.
👍️0
StevenRisk StevenRisk 3 meses hace
Wouldn't that be nice.?
👍️0
Drugdoctor Drugdoctor 3 meses hace
Trump's cabinet has moved from anti marijuana to mostly pro marijuana this coming term. I believe we finally see real progress made in the first half of 2025!
👍️0

Su Consulta Reciente

Delayed Upgrade Clock